A U.K. woman, who was diagnosed with a rare cancer, recalls having eight organs removed in what she described as 'the mother ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Faye Louise, 39, from Horsham, first felt discomfort in spring 2023 but put it down to period pains. But an ultrasound ...
A former model had eight organs removed after she was diagnosed with a rare form of cancer, but she has now returned to work ...
CBX-12 is under clinical development by Cybrexa and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...